Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 13/20 | 0.76 |
| ▸ | POLB | P06746 | 8/20 | 0.76 |
| ▸ | MEN1 | O00255 | 6/20 | 0.76 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.76 |
| ▸ | USP2 | O75604 | 2/20 | 0.76 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.76 |
| ▸ | TNNT2 | P45379 | 1/20 | 0.76 |
| ▸ | RECQL | P46063 | 1/20 | 0.76 |
| ▸ | TNNC1 | P63316 | 1/20 | 0.76 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.76 |
| ▸ | RAB9A | P51151 | 4/20 | 0.70 |
| ▸ | NPC1 | O15118 | 2/20 | 0.70 |
| ▸ | PKM | P14618 | 1/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.66 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.66 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.65 |
| ▸ | TP53 | P04637 | 4/20 | 0.61 |
| ▸ | THRB | P10828 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17799204 | 1.00 | MAPT (0.76) | MAPTPOLBMEN1KMT2AUSP2 | |
| SCHEMBL12351294 | 0.93 | MAPT (0.83) | MAPTPOLBMEN1KMT2AUSP2 | |
| SCHEMBL5594542 | 0.86 | MAPT (1.00) | MAPTPOLBMEN1KMT2AUSP2 | |
| SCHEMBL10476363 | 0.82 | MEN1 (1.00) | MAPTPOLBMEN1KMT2AUSP2 | |
| SCHEMBL14749136 | 0.82 | MAPT (0.76) | MAPTPOLBMEN1KMT2AUSP2 | |
| SCHEMBL14476502 | 0.82 | MAPT (0.86) | MAPTPOLBMEN1KMT2AUSP2 | |
| SCHEMBL10476364 | 0.78 | MAPT (0.82) | MAPTPOLBMEN1KMT2AUSP2 | |
| SCHEMBL27983596 | 0.78 | MAPT (0.78) | MAPTPOLBMEN1KMT2AUSP2 | |
| SCHEMBL5594436 | 0.77 | MAPT (0.72) | MAPTPOLBMEN1KMT2AUSP2 | |
| SCHEMBL27983608 | 0.76 | MAPT (0.82) | MAPTPOLBMEN1KMT2AUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200087648-A1 | PARKIN LIGASE ACTIVATION METHODS AND COMPOSITIONS | NYSNOBIO IRELAND DAC (IE) | 2020-03-19 | — | — | US | disclosed |
| US-10155936-B2 | Parkin ligase activation methods and compositions | An2H Discovery Limited (IE) | 2018-12-18 | — | — | US | disclosed |
| US-20160160205-A1 | PARKIN LIGASE ACTIVATION METHODS AND COMPOSITIONS | An2H Discovery Limited (IE) | 2016-06-09 | — | — | US | disclosed |
| US-20160160205-A1 | PARKIN LIGASE ACTIVATION METHODS AND COMPOSITIONS | An2H Discovery Limited (IE) | 2016-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10155936-B2 | Parkin ligase activation methods and compositions | PINK1, XIAP, STUB1 | MAPT 1156/4885POLB 611/4885MEN1 4544/4885 |
| US-20200087648-A1 | PARKIN LIGASE ACTIVATION METHODS AND COMPOSITIONS | PINK1, XIAP, STUB1 | MAPT 1156/4885POLB 611/4885MEN1 4544/4885 |
| US-20160160205-A1 | PARKIN LIGASE ACTIVATION METHODS AND COMPOSITIONS | PINK1, XIAP, STUB1 | MAPT 1156/4885POLB 611/4885MEN1 4544/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.